We used Cistrome Cancer to analyze data from The Cancer Genome atlas (TCGA) and showed that both in GBM as well as low grade gliomas (LGGs), patients with higher EZH2 expression have a worse prognosis in comparison to patients with lower EZH2 expression (Figures 1D, E). The gene discussed is EZH2; the disease is glioblastoma.